Efficacy and Safety Study to Evaluate MT-6548 in Peritoneal Dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan

Condition:   Anemia; Peritoneal Dialysis Dependent Chronic Kidney Disease Intervention:   Drug: MT-6548 Sponsor:   Mitsubishi Tanabe Pharma Corporation Recruiting

Source: ClinicalTrials.gov - January 18, 2018 Category: Research Source Type: clinical trials